Nezih OKTAR 

Current research interests:

• Longterm GBM survivals

• 1p-19q deletions in oligodendroglioma & glioma patients

• Ubiquionine, mitochondrial DNA mutations in glioma tissue culture

• Sequential fotémustine & temozolomide chemotherapy in malignant gliomas

• TMX treatment in refractory and residive meningioma, NFII & neurinoma, meningiomatosis

• Biodegradable intratumoral polymer-drug bucladesine (dbc-AMP) + systemic chemotherapy in de novo GBM patients

• Dendritic and stem cell treatment in recurrent malignant gliomas and other recurrent brain tumors

• Poryphiria gingivalis PCR DNA study in cerebral aneurysmal SAH

• Telomerase activity in recurrent chordoma patients

• Features of intravascular papillary endothelial hyperplasia of the CNS (Brain & Spinal cord)

• Chemotherapy in diffuse recurrent astrocytomas

• NADH treatment in neuronal damage & in spinal cord injury

• Impact of cyclic nucleotides on 3D multicellular tumor spheroids derived from human medulloblastoma

• Myxopapillary ependymomas clinical & pathological features

• Beta-glucan in neuro-oncology patients

• COMT and MTHFR C677T polymorphisms in brain tumors

• MDR1 expressions in brain tumors

• Survey of ENOK patients 

• Gliadel implantation in GBM & anaplastic glioma patients